NTRA Natera, Inc. $23.24B $169.34 BIIB Biogen Inc. $20.47B $139.63 INCY Incyte Corporation $16.79B $85.98 ILMN Illumina, Inc. $15.03B $97.82 TEM Tempus AI, Inc. $13.21B $78.34 MRNA Moderna, Inc. $9.41B $24.19 GH Guardant Health, Inc. $8.29B $66.51 ADPT Adaptive Biotechnologies Corporation $1.96B $12.84 TXG 10x Genomics, Inc. $1.66B $13.37 TWST Twist Bioscience Corporation $1.58B $26.24 PGEN Precigen, Inc. $1.42B $4.76 NTLA Intellia Therapeutics, Inc. $1.22B $11.40 GRAL GRAIL, Inc. $1.14B $31.61 FLGT Fulgent Genetics, Inc. $682.89M $22.31 MAZE Maze Therapeutics, Inc. $671.80M $15.32 DNA Ginkgo Bioworks Holdings, Inc. $652.38M $11.02 MYGN Myriad Genetics, Inc. $642.01M $6.90 RLAY Relay Therapeutics, Inc. $631.02M $3.66 ARCT Arcturus Therapeutics Holdings Inc. $453.48M $16.70 PSNL Personalis, Inc. $426.54M $4.81 PACB Pacific Biosciences of California, Inc. $384.47M $1.28 DSGN Design Therapeutics, Inc. $326.31M $5.73 FHTX Foghorn Therapeutics Inc. $298.48M $5.28 NEO NeoGenomics, Inc. $224.42M $8.81 MGX Metagenomi, Inc. Common Stock $68.31M $1.82 PEPG PepGen Inc. $39.36M $1.20 CAMP CAMP4 Therapeutics Corporation $31.45M $1.56 BNGO Bionano Genomics, Inc. $13.76M $4.09